Share Share on Facebook Share on Twitter Pinterest Email The post Sanofi shares slide as FDA delays MS drug decision and late-stage trial disappoints appeared first on Invezz 0 Related Posts ABB lifts its 2026 outlook: here’s what’s driving the 5% stock pop April 22, 2026 Why is Sapporo stock sliding 6% after selling its US beer unit? April 22, 2026 Japan stocks outlook lifted as JPMorgan boosts Nikkei target April 22, 2026